We are live on ! Find out more
Nuveen

Nuveen Portfolio holdings

AUM $419B
1-Year Est. Return 43.02%
This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+43.02%
3 Year Est. Return
+139.43%
5 Year Est. Return
+185.66%
10 Year Est. Return
+615.13%
AUM
$342B
AUM Growth
+$4.99B
Cap. Flow
-$5.86B
Cap. Flow %
-1.71%
Top 10 Hldgs %
31.71%
Holding
3,487
New
211
Increased
1,344
Reduced
1,316
Closed
159

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.03B
2
VLO icon
Valero Energy
VLO
+$273M
3
PGR icon
Progressive
PGR
+$259M
4
AMD icon
Advanced Micro Devices
AMD
+$256M
5
ORLY icon
O'Reilly Automotive
ORLY
+$232M

Sector Composition

Rank Sector Weight
1 Technology 31.78%
2 Financials 11.71%
3 Healthcare 11.09%
4 Consumer Discretionary 10.63%
5 Communication Services 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SKIN icon
3276
SkinHealth Systems
SKIN
$86.5M
$84K ﹤0.01%
43,730
– –
ZURA icon
3277
Zura Bio
ZURA
$387M
$82.8K ﹤0.01%
23,657
– –
LNSR icon
3278
LENSAR
LNSR
$85M
$80.4K ﹤0.01%
17,865
– –
SST icon
3279
System1
SST
$24.6M
$76.5K ﹤0.01%
5,033
– –
ACRV icon
3280
Acrivon Therapeutics
ACRV
$90M
$68.6K ﹤0.01%
11,821
– –
JBIO
3281
Jade Biosciences
JBIO
$917M
$66.5K ﹤0.01%
1,144
– –
MVST icon
3282
Microvast
MVST
$265M
$65.7K ﹤0.01%
144,054
-420,597
-74% -$189K
MRDN
3283
Meridian Holdings Inc
MRDN
$169M
$65.5K ﹤0.01%
+2,210
New +$101K
PRLD icon
3284
Prelude Therapeutics
PRLD
$310M
$64K ﹤0.01%
16,797
– –
GALT icon
3285
Galectin Therapeutics
GALT
$393M
$62.4K ﹤0.01%
+27,623
New +$83.9K
OPAD icon
3286
Offerpad Solutions Inc. Class A Common Stock
OPAD
$16.2M
$61.3K ﹤0.01%
+1,387
New +$86.1K
SLND icon
3287
Southland Holdings
SLND
$35.9M
$60K ﹤0.01%
+13,098
New +$64.6K
MKTW icon
3288
MarketWise
MKTW
$56.8M
$49.6K ﹤0.01%
2,138
– –
DADA
3289
DELISTED
Dada Nexus
DADA
$48.9K ﹤0.01%
38,800
– –
AMPX icon
3290
Amprius Technologies
AMPX
$1.42B
$16.6K ﹤0.01%
13,071
– –
DNA icon
3291
Ginkgo Bioworks
DNA
$718M
$8.96K ﹤0.01%
670
-107,207
-99% -$3.2M
ADVWW
3292
DELISTED
Advantage Solutions Warrant
ADVWW
$3.5K ﹤0.01%
+10,558
New +$879
ACET icon
3293
Adicet Bio
ACET
$84.4M
– –
-25,665
Closed -$965K
ACRS icon
3294
Aclaris Therapeutics
ACRS
$758M
– –
-166,656
Closed -$207K
ALLK
3295
DELISTED
Allakos
ALLK
– –
-253,367
Closed -$319K
ALV icon
3296
Autoliv
ALV
$8.61B
– –
-84,357
Closed -$10.2M
AMLX icon
3297
Amylyx Pharmaceuticals
AMLX
$3.76B
– –
-137,973
Closed -$392K
AMWL icon
3298
American Well
AMWL
$228M
– –
-35,380
Closed -$574K
ARTNA icon
3299
Artesian Resources
ARTNA
$343M
– –
-23,052
Closed -$855K
ASRT
3300
DELISTED
Assertio
ASRT
– –
-14,443
Closed -$208K

Similar funds

Nuveen's Q2 2024 Portfolio in Review

As of Q2 2024, Nuveen held 3,487 positions worth $342B, up 1.5% from $337B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Nuveen's Q2 2024 filing shows 211 new, 1,344 increased, 1,316 reduced and 159 closed positions. Its largest new stake was GE Vernova: 595,802 shares worth $102M. The largest sale was Meta Platforms (Facebook), an estimated $466M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q2 2024 buy was GE Vernova: 595,802 shares worth $102M.
  • Nuveen added most to Apple in Q2 2024, an estimated $1.03B increase.
  • Nuveen's biggest Q2 2024 reduction was Meta Platforms (Facebook), cutting an estimated $466M.
  • Nuveen fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $389M.
  • Nuveen's ten largest holdings make up 32% of its $342B portfolio in Q2 2024.
  • Nuveen opened 211 new positions and closed 159 in Q2 2024.
  • Nuveen's portfolio value rose 1.5% quarter-over-quarter to $342B.

Based on Nuveen's 13F filing for Q2 2024, filed 9 Aug 2024.